BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20944137)

  • 21. Prognostic significance of mutant p53 protein, P-glycoprotein and glutathione S-transferase-pi in patients with unresectable non-small cell lung cancer.
    Miyatake K; Gemba K; Ueoka H; Nishii K; Kiura K; Tabata M; Shibayama T; Takigawa N; Kawaraya M; Tanimoto M
    Anticancer Res; 2003; 23(3C):2829-36. PubMed ID: 12926120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
    Katiyar SK; Meeran SM; Katiyar N; Akhtar S
    Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlations between intrinsic chemoresistance and HER-2/neu gene expression, p53 gene mutations, and cell proliferation characteristics in non-small cell lung cancer cell lines.
    Tsai CM; Chang KT; Wu LH; Chen JY; Gazdar AF; Mitsudomi T; Chen MH; Perng RP
    Cancer Res; 1996 Jan; 56(1):206-9. PubMed ID: 8548764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accumulation, platinum-DNA adduct formation and cytotoxicity of cisplatin, oxaliplatin and satraplatin in sensitive and resistant human osteosarcoma cell lines, characterized by p53 wild-type status.
    Martelli L; Di Mario F; Botti P; Ragazzi E; Martelli M; Kelland L
    Biochem Pharmacol; 2007 Jun; 74(1):20-7. PubMed ID: 17466278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ser392 phosphorylation regulates the oncogenic function of mutant p53.
    Yap DB; Hsieh JK; Zhong S; Heath V; Gusterson B; Crook T; Lu X
    Cancer Res; 2004 Jul; 64(14):4749-54. PubMed ID: 15256442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The subunits of glutamate cysteine ligase enhance cisplatin resistance in human non-small cell lung cancer xenografts in vivo.
    Fujimori S; Abe Y; Nishi M; Hamamoto A; Inoue Y; Ohnishi Y; Nishime C; Matsumoto H; Yamazaki H; Kijima H; Ueyama Y; Inoue H; Nakamura M
    Int J Oncol; 2004 Aug; 25(2):413-8. PubMed ID: 15254739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The modifier subunit of glutamate cysteine ligase relates to cisplatin resistance in human small cell lung cancer xenografts in vivo.
    Nishi M; Abe Y; Fujimori S; Hamamoto A; Inoue Y; Miyazaki N; Oida Y; Ikoma N; Ohnishi Y; Yamazaki H; Ueyama Y; Nakamura M
    Oncol Rep; 2005 Aug; 14(2):421-4. PubMed ID: 16012725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of wild-type and mutant E-cadherin on cell proliferation and responsiveness to the chemotherapeutic agents cisplatin, etoposide, and 5-fluorouracil.
    Fricke E; Hermannstädter C; Keller G; Fuchs M; Brunner I; Busch R; Höfler H; Becker KF; Luber B
    Oncology; 2004; 66(2):150-9. PubMed ID: 15138368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transient stabilization of p53 in non-small cell lung carcinoma cultures arrested for growth by retinoic acid.
    Maxwell SA; Mukhopadhyay T
    Exp Cell Res; 1994 Sep; 214(1):67-74. PubMed ID: 8082749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aberrant p53 expression predicts clinical resistance to cisplatin-based chemotherapy in locally advanced non-small cell lung cancer.
    Rusch V; Klimstra D; Venkatraman E; Oliver J; Martini N; Gralla R; Kris M; Dmitrovsky E
    Cancer Res; 1995 Nov; 55(21):5038-42. PubMed ID: 7585548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated p53 and p21waf1 mRNA expression in blood lymphocytes from lung cancer patients with chemoresistance.
    Shih CM; Chen K; Wang YC; Lee PJ; Wang YC
    Cancer Detect Prev; 2007; 31(5):366-70. PubMed ID: 18035504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The evaluation of gastric cancer sensitivity to 5-FU/CDDP in terms of induction of apoptosis: time- and p53 expression-dependency of anti-cancer drugs.
    Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S
    Oncol Rep; 2005 Sep; 14(3):609-15. PubMed ID: 16077963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. P53-independent thermosensitization by mitomycin C in human non-small-cell lung cancer cells.
    Jin ZH; Matsumoto H; Hayashi S; Hatashita M; Ohtsubo T; Shioura H; Kitai R; Kano E
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):852-60. PubMed ID: 15183489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Role of Smac in cisplatin-induced apoptosis of non-small cell lung cancer cells].
    Cheng XD; Cai SX; Zhao HJ; Li WJ; Tong WC
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):389-91. PubMed ID: 18359697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53 status and its in vitro relationship to radiosensitivity and chemosensitivity in lung cancer.
    Bergqvist M; Brattström D; Gullbo J; Hesselius P; Brodin O; Wagenius G
    Anticancer Res; 2003; 23(2B):1207-12. PubMed ID: 12820372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin C increases the apoptosis via up-regulation p53 during cisplatin treatment in human colon cancer cells.
    An SH; Kang JH; Kim DH; Lee MS
    BMB Rep; 2011 Mar; 44(3):211-6. PubMed ID: 21429301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal expression pattern of the ASPP family of proteins in human non-small cell lung cancer and regulatory functions on apoptosis through p53 by iASPP.
    Li S; Shi G; Yuan H; Zhou T; Zhang Q; Zhu H; Wang X
    Oncol Rep; 2012 Jul; 28(1):133-40. PubMed ID: 22552744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Relationship between survivin expression and chemosensitivity of human lung cancer cells].
    Yang H; Fu JH; Hu Y; Huang WZ; Zheng B; Wang G
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(27):1934-7. PubMed ID: 17923022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53-regulated GML gene expression in non-small cell lung cancer. a promising relationship to cisplatin chemosensitivity.
    Higashiyama M; Miyoshi Y; Kodama K; Yokouchi H; Takami K; Nishijima M; Nakayama T; Kobayashi H; Minamigawa K; Nakamura Y
    Eur J Cancer; 2000 Mar; 36(4):489-95. PubMed ID: 10717525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prediction of a non-small cell lung cancer sensitivity to cisplatin and paclitaxel based on the marker genes expression].
    Boiarskikh UA; Kondrakhin IuV; Evshin IS; Sharipov RN; Komel'kov AV; Musatkina EA; Chevkina EM; Sukoian MA; Kolpakov FA; Kashkin KN; Filipenko ML
    Mol Biol (Mosk); 2011; 45(4):652-61. PubMed ID: 21954597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.